189 related articles for article (PubMed ID: 24072491)
1. COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death.
He M; Wang Z; Zhao J; Chen Y; Wu Y
Tumour Biol; 2014 Feb; 35(2):1297-305. PubMed ID: 24072491
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.
Liu JY; Zhu BR; Wang YD; Sun X
Int J Clin Oncol; 2020 Jun; 25(6):1195-1205. PubMed ID: 32215805
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
[TBL] [Abstract][Full Text] [Related]
5. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.
Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S
Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma.
Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M
Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variant of
Xu L; Ni J; Wang Y; Dong Y; Wang S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819874802. PubMed ID: 31522615
[TBL] [Abstract][Full Text] [Related]
8. Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population.
Hu YS; Pan Y; Li WH; Zhang Y; Li J; Ma BA
Med Oncol; 2011 Jun; 28(2):622-5. PubMed ID: 20354825
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 10 gene -1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population.
Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY
Tumour Biol; 2016 Apr; 37(4):4517-22. PubMed ID: 26503210
[TBL] [Abstract][Full Text] [Related]
10. GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population.
Jiang C; Chen H; Shao L; Dong Y
Med Oncol; 2014 Jul; 31(7):50. PubMed ID: 24984297
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.
Koster R; Panagiotou OA; Wheeler WA; Karlins E; Gastier-Foster JM; Caminada de Toledo SR; Petrilli AS; Flanagan AM; Tirabosco R; Andrulis IL; Wunder JS; Gokgoz N; Patiño-Garcia A; Lecanda F; Serra M; Hattinger C; Picci P; Scotlandi K; Thomas DM; Ballinger ML; Gorlick R; Barkauskas DA; Spector LG; Tucker M; Belynda DH; Yeager M; Hoover RN; Wacholder S; Chanock SJ; Savage SA; Mirabello L
Int J Cancer; 2018 Apr; 142(8):1594-1601. PubMed ID: 29210060
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in COL18A1 influence the development of osteosarcoma.
Guo Z; Zhang T; Wu J; Wang H; Liu X; Tian L
Int J Clin Exp Pathol; 2015; 8(9):11531-6. PubMed ID: 26617886
[TBL] [Abstract][Full Text] [Related]
13. Association and linkage analysis of COL1A1 and AHSG gene polymorphisms with femoral neck bone geometric parameters in both Caucasian and Chinese nuclear families.
Jiang H; Lei SF; Xiao SM; Chen Y; Sun X; Yang F; Li LM; Wu S; Deng HW
Acta Pharmacol Sin; 2007 Mar; 28(3):375-81. PubMed ID: 17303000
[TBL] [Abstract][Full Text] [Related]
14. Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.
He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
Endocrine; 2014 Mar; 45(2):325-30. PubMed ID: 24078408
[TBL] [Abstract][Full Text] [Related]
15. Association between angiogenic growth factor genetic polymorphisms and the risk of osteosarcoma.
Zhang HF; Yan JP; Zhuang YS; Han GQ
Genet Mol Res; 2015 Sep; 14(3):10524-9. PubMed ID: 26400284
[TBL] [Abstract][Full Text] [Related]
16. Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese.
He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
Endocr J; 2013; 60(11):1215-20. PubMed ID: 23933591
[TBL] [Abstract][Full Text] [Related]
17. Associations of polymorphisms in the bone morphogenetic protein-2 gene with risk and prognosis of osteosarcoma in a Chinese population.
Cong Y; Li CJ; Zhao JN; Liu XZ; Shi X
Tumour Biol; 2015 Mar; 36(3):2059-64. PubMed ID: 25391427
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of HER2 related to osteosarcoma susceptibility.
Xin DJ; Shen GD; Song J
Int J Clin Exp Pathol; 2015; 8(8):9494-9. PubMed ID: 26464710
[TBL] [Abstract][Full Text] [Related]
19. Association of -308G/A and -238G/A polymorphisms of TNF-α and osteosarcoma risk.
Zhao Z; Tang X; Song K; Li X; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):4177-81. PubMed ID: 26097610
[TBL] [Abstract][Full Text] [Related]
20. CD86 + 1057G/A polymorphism and susceptibility to osteosarcoma.
Wang W; Song H; Liu J; Song B; Cao X
DNA Cell Biol; 2011 Nov; 30(11):925-9. PubMed ID: 21563968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
